Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Arch Capital
ACGL
$33.2B
| $12.4M | 0.01% |
433,696
-2,315,204
| -84% | -$64M |
|
1102
Cheesecake Factory
CAKE
$5.57B
| $12.4M | 0.01% |
+541,145
| New | +$11.4M |
|
1103
Maximus
MMS
$2.94B
| $12.4M | 0.01% |
175,900
+34,700
| +25% | +$2.33M |
|
1104
SFL Corp
SFL
$1.57B
| $12.4M | 0.01% |
1,331,565
+5,468
| +0.4% | +$54.7K |
|
|
CIT
1105
DELISTED
CIT Group Inc.
CIT
| $12.4M | 0.01% |
+596,102
| New | +$11.5M |
|
|
SHI
1106
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $12.3M | 0.01% |
516,217
+54,900
| +12% | +$1.42M |
|
1107
iShares Core US Aggregate Bond ETF
AGG
$138B
| $12.3M | 0.01% |
103,700
+89,300
| +620% | +$10.5M |
|
|
CYBR
1108
DELISTED
CyberArk
CYBR
| $12.2M | 0.01% |
123,388
+85,088
| +222% | +$8.28M |
|
|
HDS
1109
DELISTED
HD Supply Holdings, Inc.
HDS
| $12.2M | 0.01% |
353,100
+163,800
| +87% | +$5.08M |
|
1110
Invesco Ultra Short Duration ETF
GSY
$3.88B
| $12.2M | 0.01% |
242,500
+114,000
| +89% | +$5.71M |
|
|
TNAV
1111
DELISTED
Telenav Inc.
TNAV
| $12.2M | 0.01% |
2,224,491
+93,800
| +4% | +$464K |
|
1112
Methode Electronics
MEI
$602M
| $12.2M | 0.01% |
389,680
-29,400
| -7% | -$881K |
|
|
ADVM
1113
DELISTED
Adverum Biotechnologies
ADVM
| $12.2M | 0.01% |
58,295
-50,120
| -46% | -$8.88M |
|
|
QVCGA
1114
DELISTED
QVC Group Inc Series A
QVCGA
| $12.2M | 0.01% |
+26,357
| New | +$10.3M |
|
1115
Star Group
SGU
$417M
| $12.2M | 0.01% |
1,385,655
+93,300
| +7% | +$736K |
|
|
CLGX
1116
DELISTED
Corelogic, Inc.
CLGX
| $12.1M | 0.01% |
180,096
-714,814
| -80% | -$31.8M |
|
1117
Mativ Holdings
MATV
$690M
| $12.1M | 0.01% |
361,098
-221,000
| -38% | -$6.65M |
|
1118
Bread Financial
BFH
$4.51B
| $12M | 0.01% |
+334,604
| New | +$11.9M |
|
1119
McGrath RentCorp
MGRC
$2.94B
| $12M | 0.01% |
222,603
-132,200
| -37% | -$7.1M |
|
1120
AeroVironment
AVAV
$9.59B
| $12M | 0.01% |
+150,439
| New | +$9.69M |
|
1121
Freedom Holding
FRHC
$9.65B
| $12M | 0.01% |
640,909
+481,700
| +303% | +$8M |
|
1122
Enterprise Financial Services Corp
EFSC
$2.41B
| $12M | 0.01% |
384,700
-105,700
| -22% | -$3.07M |
|
|
LBAI
1123
DELISTED
Lakeland Bancorp Inc
LBAI
| $11.9M | 0.01% |
1,040,600
-107,600
| -9% | -$1.16M |
|
|
SAGE
1124
DELISTED
Sage Therapeutics
SAGE
| $11.9M | 0.01% |
285,800
-461,332
| -62% | -$16.7M |
|
|
CO
1125
DELISTED
Global Cord Blood Corporation
CO
| $11.8M | 0.01% |
3,817,062
+576,864
| +18% | +$1.68M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.